Prediction of failure in vancomycin-treated methicillin-resistant Staphylococcus aureus bloodstream infection: a clinically useful risk stratification tool.

@article{Moore2011PredictionOF,
  title={Prediction of failure in vancomycin-treated methicillin-resistant Staphylococcus aureus bloodstream infection: a clinically useful risk stratification tool.},
  author={Carol L. Moore and Mei Zhen Lu and Faiqa A Cheema and Paola Osaki-Kiyan and Mary Beth Perri and Susan Donabedian and Nadia Z. Haque and Marcus John Zervos},
  journal={Antimicrobial agents and chemotherapy},
  year={2011},
  volume={55 10},
  pages={
          4581-8
        }
}
Methicillin-resistant Staphylococcus aureus (MRSA) is a common cause of bloodstream infection (BSI) and is often associated with invasive infections and high rates of mortality. Vancomycin has remained the mainstay of therapy for serious Gram-positive infections, particularly MRSA BSI; however, therapeutic failures with vancomycin have been increasingly reported. We conducted a comprehensive evaluation of the factors (patient, strain, infection, and treatment) involved in the etiology and… CONTINUE READING
Tweets
This paper has been referenced on Twitter 5 times. VIEW TWEETS

Figures, Tables, and Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 22 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 33 REFERENCES

Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections

  • Hsu, I D.
  • Int. J. Antimicrob. Agents
  • 2008
Highly Influential
4 Excerpts

Comparative evaluation of epidemiology and outcomes of methicillin-resistant Staphylococcus aureus (MRSA) USA300 infections causing community- and healthcare-associated infections

  • C Moore
  • Int. J. Antimicrob. Agents 34:148–155
  • 2009
1 Excerpt

Similar Papers

Loading similar papers…